Effect of Lower Extremity Traction on the Popliteal Angle After Percutaneous Needle Tenotomy of the Knee Flexor Muscles.

People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at risk of neuro-orthopaedic disorders. Microinvasive percutaneous needle tenotomy is a frequent use alternative to open surgery to treat limb deformities. A lower extremity traction is performed in our unit during 2 to 7 days after surgery of the knee flexor muscles.

The aim of this study is to describe the efficiency of lower extremity traction on the popliteal angle after percutaneous needle tenotomy of the knee flexor muscles.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This is a prospective, monocentric, cohort study of neurological disabled inpatients subjects treated in the perioperative disability unit (UPOH) of our university hospital for limb deformities by percutaneous needle tenotomy of the knee flexor muscles.

All eligible inpatient subjects with neuromotor disability and admitted for the treatment of limb deformities by percutaneous needle tenotomy of the knee flexor muscles will be consecutively included.

Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological, and physiological examinations.

This is a routine care study; no procedures are added for research purposes. It is an ancillary study to the NO-AGING study.

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Garches, France, 92380
        • Recruiting
        • Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP
        • Sub-Investigator:
          • Marjorie Salga
        • Contact:
          • Vincent T Carpentier
        • Sub-Investigator:
          • Laure Gatin
        • Sub-Investigator:
          • Sylvain Petit
        • Sub-Investigator:
          • Fabien Calé
        • Sub-Investigator:
          • Bernard Hollier-Larousse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects with neuromotor disability and admitted for the treatment of limb deformities by percutaneous needle tenotomy of the knee flexor muscles.

Description

Inclusion Criteria:

  • Patients >= 18 years old ;
  • Treated in the Perioperative Disability Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital;
  • Admitted for the treatment of limb deformities by percutaneous needle tenotomy of the knee flexor muscles ;
  • Having a neuromotor disability;
  • No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it;
  • Affiliation to a social security scheme.

Exclusion Criteria:

  • Associated open surgery ;
  • Associated bone surgery ;
  • Under court protection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Subjects admitted for percutaneous needle tenotomy of the knee flexor muscles
Postoperative lower extremity traction.
Postoperative lower extremity traction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Popliteal angle at the end of the traction
Time Frame: Daily, during the traction (up to 7 days).
Difference in popliteal angle between the beginning and end of traction, evaluated with the Kinovea angle measurement tool. In case of bilateral traction, the average of the differences of each limb will be considered.
Daily, during the traction (up to 7 days).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of surgery
Time Frame: At 30 days after surgery
Evaluated by the Goal Assessment Scale (GAS). Minimum and maximum values : -2 (worse outcome) / +2 (better outcome)
At 30 days after surgery
Popliteal angle
Time Frame: Daily, during the traction (up to 7 days).
Evaluated by goniometry or Kinovea
Daily, during the traction (up to 7 days).
Knee angle
Time Frame: Daily, during the traction (up to 7 days).
Evaluated by goniometry or Kinovea
Daily, during the traction (up to 7 days).
Pain
Time Frame: Daily, during the traction (up to 7 days).
Numeric scale or Algoplus according to disability. Minimum and maximum values for the Numeric scale : 0 (no pain) / 10 (worst pain). Minimum and maximum values for the Algoplus scale : 0 (no pain) / 5 (worst pain).
Daily, during the traction (up to 7 days).
Skin condition
Time Frame: Daily, during the traction (up to 7 days).
Presence of erythema, phlyctens or superficial pressure sores
Daily, during the traction (up to 7 days).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: François Genêt, MD-PhD, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France
  • Study Director: Vincent T. Carpentier, MD-MSc, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP, 92380 Garches, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2023

Primary Completion (Anticipated)

January 31, 2024

Study Completion (Anticipated)

February 28, 2024

Study Registration Dates

First Submitted

February 6, 2023

First Submitted That Met QC Criteria

February 16, 2023

First Posted (Actual)

February 21, 2023

Study Record Updates

Last Update Posted (Actual)

March 3, 2023

Last Update Submitted That Met QC Criteria

March 2, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability or Chronic Disease Leading to Disablement

Clinical Trials on Traction

Subscribe